Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Anti Radiation Drugs Companies

ID: MRFR/Pharma/10741-HCR
130 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Anti-radiation drugs, also known as radioprotective agents, are medications designed to protect cells and tissues from the harmful effects of ionizing radiation. These drugs may be used in situations where individuals are exposed to high levels of radiation, such as during certain medical treatments, nuclear accidents, or radiation therapy.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Anti Radiation Drugs Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)10.2%
2024 Market Size$ 4.36 Billion
2025 Market Size$ 4.81 Billion
2035 Market Size$ 12.7 Billion

Key Players

Bristol-Myers Squibb
Merck & Co.
Pfizer Inc.
Eli Lilly and Company
Novartis AG
Bayer AG
Opportunities
  • Government Initiatives and Funding
  • Emerging Markets and Global Expansion
  • Rising Demand from Healthcare Providers

Top Industry Leaders in the Anti Radiation Drugs Market

Anti-Radiation Drugs Key Companies
ย 
Latestย Anti-Radiation Drugsย Companies Update:

Amgen Nplate remains the only FDA-approved drug for ARS treatment, positioning Amgen as a key player in the market. The recent US government purchase further strengthens their position.

Anbex The company is developing HEMATO-STEM, a potential candidate for ARS treatment in late-stage clinical trials. Positive results could significantly impact the market landscape.

Chrysalis BioTherapeutics Acquired the exclusive US rights to PLG02, another late-stage ARS treatment candidate, potentially entering the market soon.

List ofย Anti-Radiation Drugsย Key companies in the market
  • Amgen Inc.
  • Anbex Inc.
  • Arco Pharmaceuticals LLC
  • BTG International Inc.
  • Cellphire, Inc.
  • Chrysalis BioTherapeutics, Inc.
  • Darnitsa
  • Enzychem Lifesciences Corporation
  • Humanetics Corporation
  • Mission Pharmacal Company
  • Myelo Therapeutics GmbH
  • Partner Therapeutics
  • Pluri Inc.